Tumor Biology

, Volume 36, Issue 1, pp 421–428 | Cite as

Knockdown of Rho-associated protein kinase 1 suppresses proliferation and invasion of glioma cells

Research Article


Rho-associated protein kinase 1 (ROCK1), a serine/threonine protein kinase, affects cell invasion and migration by changing the status of the cytoskeleton. In recent years, ROCK1 was found to be overexpressed in a variety of tumors. However, the information of ROCK1 in glioma still remains elusive. In our study, the expression of ROCK1 in glioma tissues was examined by real-time PCR and the relationship between ROCK1 expression and clinical characteristics of patients with glioma was also analyzed. With the inhibition of ROCK1 expression by RNAi, the effects of ROCK1 on biological behaviors of glioma cells including cell viability, cell cycle, and cell invasion were probed in the U251 cell line by methyl thiazolyl tetrazolium (MTT) assay, flow cytometer analysis, and Transwell invasion experiment. In addition, the effects of ROCK1 on the regulation of Ki67, cyclin D1, matrix metalloproteinases 9 (MMP9), and E-cadherin were also investigated. The results indicated that ROCK1 messenger RNA (mRNA) was increased significantly compared to that in the adjacent normal tissue (P < 0.05) and the expression level of ROCK1 mRNA in high-grade malignant glioma tissue was significantly higher than that in low-grade malignant glioma tissue (P < 0.05). MTT assay and flow cytometer analysis revealed that the cell viability and cell proliferation in the ROCK1 small interfering RNA (siRNA) transfection group were markedly lower than those in the blank or negative control group (P < 0.05), and no obvious differences were found between the blank group and negative control group. The Transwell invasion experiments showed that the invasive ability of U251 cells in the ROCK1 siRNA transfection group was obviously lower than that in the blank or negative control group (P < 0.05), and there were no visible differences between the blank group and negative control group. Western blot demonstrated that the protein levels of Ki67, cyclin D1, and MMP9 in the ROCK1 siRNA transfection group were distinctly lower than those in the blank or negative control group (P < 0.05) and that the protein level of E-cadherin displayed an opposite variation (P < 0.05). In summary, the expressions of ROCK1 in glioma tissue were visibly upregulated and the increase of ROCK1 had a positive correlation with the malignant grade of glioma. The results implied that the proliferation and metastasis of the glioma cell could be inhibited by suppressing the expression of ROCK1, and our findings would provide a new target for intervention and treatment of glioma.


ROCK1 Glioma Proliferation Migration siRNA 


  1. 1.
    Liu C, Zong H. Developmental origins of brain tumors. Curr Opin Neurobiol. 2012;22:844–9.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Wang MH, Lin CL, Zhang JJ, Weng ZP, Hu T, Xie Q, et al. Role of PTEN in cholera toxin-induced SWO38 glioma cell differentiation. Mol Med Rep. 2013;7:1912–8.PubMedGoogle Scholar
  3. 3.
    Aibaidula A, Lu JF, Wu JS, Zou HJ, Chen H, Wang YQ, et al. Establishment and maintenance of a standardized glioma tissue bank: Huashan experience. Cell Tissue Bank. 2014. doi: 10.1007/s10561-10014-19459-10564.PubMedGoogle Scholar
  4. 4.
    Scott RW, Crighton D, Olson MF. Modeling and imaging 3-dimensional collective cell invasion. J Vis Exp. 2011. doi: 10.3791/3525.Google Scholar
  5. 5.
    Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629–35.CrossRefPubMedGoogle Scholar
  6. 6.
    Tang AT, Campbell WB, Nithipatikom K. ROCK1 feedback regulation of the upstream small GTPase RhoA. Cell Signal. 2012;24:1375–80.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11:9–22.CrossRefPubMedGoogle Scholar
  8. 8.
    Goidts V, Szamalek JM, Hameister H, Kehrer-Sawatzki H. Segmental duplication associated with the human-specific inversion of chromosome 18: a further example of the impact of segmental duplications on karyotype and genome evolution in primates. Hum Genet. 2004;115:116–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Morgan-Fisher M, Wewer UM, Yoneda A. Regulation of ROCK activity in cancer. J Histochem Cytochem. 2013;61:185–98.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wen W, Liu W, Yan J, Zhang M. Structure basis and unconventional lipid membrane binding properties of the Ph-C1 tandem of rho kinases. J Biol Chem. 2008;283:26263–73.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton. 2010;67:545–54.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, et al. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS ONE. 2014;9:e85205.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cui G, Cui M, Li Y, Liang Y, Li W, Guo H, et al. MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. Tumour Biol. 2014. doi: 10.1007/s13277-13014-12168-13276.Google Scholar
  14. 14.
    Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, et al. ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res. 2011;29:1259–66.CrossRefPubMedGoogle Scholar
  15. 15.
    Brown M, Roulson JA, Hart CA, Tawadros T, Clarke NW. Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer. Br J Cancer. 2014;110:2099–108.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R, et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res. 2011;17:7574–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Zhao Y, Lv M, Lin H, Hong Y, Yang F, Sun Y, et al. ROCK1 induces ERK nuclear translocation in PDGF-BB-stimulated migration of rat vascular smooth muscle cells. IUBMB Life. 2012;64:194–202.CrossRefPubMedGoogle Scholar
  18. 18.
    Monga SP. Role and regulation of beta-catenin signaling during physiological liver growth. Gene Expr. 2014;16:51–62.CrossRefPubMedGoogle Scholar
  19. 19.
    Huang M, Tang SN, Upadhyay G, Marsh JL, Jackman CP, Srivastava RK, et al. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from KrasG12D mice. Cancer Lett. 2014;353:32–40.CrossRefPubMedGoogle Scholar
  20. 20.
    Butt S, Borgquist S, Anagnostaki L, Landberg G, Manjer J. Breastfeeding in relation to risk of different breast cancer characteristics. BMC res notes. 2014;7:216.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Xu YB, Du QH, Zhang MY, Yun P, He CY. Propofol suppresses proliferation, invasion and angiogenesis by down-regulating ERK-VEGF/MMP-9 signaling in Eca-109 esophageal squamous cell carcinoma cells. Eur Rev Med Pharmacol Sci. 2013;17:2486–94.PubMedGoogle Scholar
  22. 22.
    Cock-Rada AM, Medjkane S, Janski N, Yousfi N, Perichon M, Chaussepied M, et al. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Res. 2012;72:810–20.CrossRefPubMedGoogle Scholar
  23. 23.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, et al. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989;16:49–58.CrossRefPubMedGoogle Scholar
  24. 24.
    Rolland Y, Marighetti P, Malinverno C, Confalonieri S, Luise C, Ducano N, et al. The CDC42-interacting protein 4 controls epithelial cell cohesion and tumor dissemination. Dev Cell. 2014;30:553–68.CrossRefPubMedGoogle Scholar
  25. 25.
    Kroiss A, Vincent S, Decaussin-Petrucci M, Meugnier E, Viallet J, Ruffion A, et al. Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2. Oncogene. 2014. doi: 10.1038/onc.2014.1222.PubMedGoogle Scholar
  26. 26.
    Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res. 1995;217:205–16.CrossRefPubMedGoogle Scholar
  27. 27.
    Okumura N, Nakano S, Kay EP, Numata R, Ota A, Sowa Y, et al. Involvement of cyclin D and p27 in cell proliferation mediated by rock inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2014;55:318–29.CrossRefPubMedGoogle Scholar
  28. 28.
    Dangi-Garimella S, Redig AJ, Shields MA, Siddiqui MA, Munshi HG. Rho-rock-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J Biol Chem. 2010;285:28363–72.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Chen R, Cheng Y, Zhang Y, Li Z, Geng L. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway. Int J Gynecol Cancer. 2014;24:184–91.CrossRefPubMedGoogle Scholar
  30. 30.
    Raviraj V, Fok S, Zhao J, Chien HY, Lyons JG, Thompson EW, et al. Regulation of ROCK1 via Notch1 during breast cancer cell migration into dense matrices. BMC Cell Biol. 2012;13:12.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Xu X, Li S, Lin Y, Chen H, Hu Z, Mao Y, et al. MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1. J Transl Med. 2013;11:276.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Smith AL, Dohn MR, Brown MV, Reynolds AB. Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin. Mol Biol Cell. 2012;23:99–110.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65:3756–88.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Peng Zhang
    • 1
  • Ying Lu
    • 2
  • Xue You Liu
    • 3
  • Yu Hua Zhou
    • 4
  1. 1.Neurosurgery DepartmentYi He Hospital of ZhengzhouZhengzhouChina
  2. 2.Nursing School of Xinxiang Medical UniversityXinxiangChina
  3. 3.Neurosurgery DepartmentYi He Hospital of ZhengzhouZhengzhouChina
  4. 4.Intensive Care UnitThe Third Affiliated Hospital of Xinxiang Medical UniversityXinxiangChina

Personalised recommendations